Molnupiravir manufacturers and suppliers

Molnupiravir suppliers

Molnupiravir

CAS:: 2349386-89-4

MF:: C13H19N3O7

MW:: 329.31

Suppliers by country/region

Company Type

Properties

Melting point:: 156 - 159°C

storage temp.: -20°C, Inert atmosphere

solubility: DMSO (Slightly), Methanol (Slightly)

form: Solid

color: White to Off-White

InChI: InChI=1/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/s3

InChIKey: HTNPEHXGEKVIHG-JFPRWSRANA-N

SMILES: O[C@@H]1[C@@H]([C@@H](COC(=O)C(C)C)O[C@H]1N1C=C/C(=N/O)/NC1=O)O |&1:1,2,3,12,r|

Safety Information

Symbol(GHS): GHS08

Signal word: Danger

Hazard statements: H372

Precautionary statements: P260-P264-P270-P314-P501

Use

Molnupiravir (EIDD-2801/MK-4482) is an investigational, orally bioavailable form of a potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19. Molnupiravir has been shown to be active in several models of SARS-CoV-2, including for prophylaxis, treatment and prevention of transmission, as well as SARS-CoV-1 and MERS. EIDD-2801 was invented at Drug Innovations at Emory (DRIVE), LLC, a not-for-prot biotechnology company wholly owned by Emory University, and with partial funding support from the U.S. government. Since licensed by Ridgeback, all funds used for the development of EIDD-2801 by Ridgeback have been provided by Wayne and Wendy Holman and Merck.

You can find Molnupiravir suppliers, manufacturers, and distributors from countries such as CHINA, India and the United States here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.